e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Advancing therapies for cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Individual treatment of cystic fibrosis by using intestinal organoids
Florijn Dekkers (Utrecht, Netherlands)
Source:
International Congress 2015 – Advancing therapies for cystic fibrosis
Session:
Advancing therapies for cystic fibrosis
Session type:
Hot topics
Number:
1736
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Florijn Dekkers (Utrecht, Netherlands). Individual treatment of cystic fibrosis by using intestinal organoids. International Congress 2015 – Advancing therapies for cystic fibrosis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Intestinal organoids to model cystic fibrosis
Source: Eur Respir J, 54 (1) 1802379; 10.1183/13993003.02379-2018
Year: 2019
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019
Year: 2021
Cystic fibrosis and intestinal organoids
Source: ERN-LUNG 2021: Cystic fibrosis and intestinal organoids
Year: 2021
Investigation of the status of cystic fibrosis airway epithelial cells
Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy
Year: 2008
Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012
Distribution and characterisation of lung mast cells in cystic fibrosis
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Lung stem cells and therapy for cystic fibrosis
Source: Eur Respir Monogr 2021; 91: 306-321
Year: 2021
Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
Source: Eur Respir J 2015; 45: 428-439
Year: 2015
Proteomics characterisation of nasal epithelial cells in cystic fibrosis
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
What damages the cystic fibrosis lung epithelium: host or microbe?
Source: Virtual Congress 2021 – Innate immunity and lung epithelial repair: what really happens?
Year: 2021
Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
Source: Eur Respir J, 52 (3) 1702529; 10.1183/13993003.02529-2017
Year: 2018
Is mitochondria morphology altered in epithelial cells with cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
Expansion of small sputum macrophages in cystic fibrosis airways
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Update on pancreatic and liver disease in cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept